Skip to main content
Log in

Synthesis and antibacterial activity of new chiral N-sulfamoyloxazolidin-2-ones

  • Published:
Journal of Chemical Sciences Aims and scope Submit manuscript

Abstract

A new series of N, \(N^{\prime }\)-bis-oxazolidinones-sulfone and 5-chloromethylsulfamoyl-oxazolidin-2-ones have been synthesized in three steps (carbamoylation, sulfamoylation and cyclization) starting from 1,3-dichloroporopan-2-ol, chlorosulfonyl isocyanate and primary or secondary amines. Synthesis has been carried out following simple methodology in excellent isolated yields. The structure and purity of the original compounds were confirmed by IR, NMR, and MS. The compounds were evaluated for their in vitro antibacterial activity against some Gram-positive bacteria; Staphylococcus aureus and Gram-negative bacteria; Escherichia Coli, Klebsiella pneumonieae, Acinetobacter, Pseudomonas aeruginosa, Enterococcus, Salmonella sp. The compounds showed moderate to good antibacterial activity.

We have developed the synthesis of news series of 5-chloromethylsulfamoyl-oxazolidinone and N,N'-bis-oxazolidinones-sulfone in three steps, starting from 1,3-dichloroporopan-2-ol, and chlorosulfonyl isocyanate. The structure of all compounds was confirmed by usual spectroscopic methods. The in vitro antibacterial activity of these compounds was evaluated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Scheme 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. (a) Raether W and Hanel H 2003 Parasitol. Res. 219; (b) Fluit A C, Schmitz F J, Verhoef J and Milatovic D 2002 J. Antimicrob. Chemother. 50 271; (c) Robert L, Goldenberg M D, John C, Hauth M D and William W A 2000 N. Engl. J. Med. 342 1500; (d) Kavita d, Yumna A, Meenakshi A, Swapnil S and Jaya D 2013 J. Chem. Sci. 125 1093

  2. Brichner S J, Hutchinson D K, Barbachyn M R, Manninen P R, Ulanowicz D A, Garmono S A, Grega K C, Hendges S K, Toops D S, Ford C W and Zurenko G E 1996 J. Med. Chem. 39 673

    Article  Google Scholar 

  3. Patel R, Rouse M S, Piper K E and Steckelberg J M 1999 Diagn. Microbiol. Infect. Dis. 34 119

    Article  CAS  Google Scholar 

  4. Gonzales R D, Schreckenberger P C, Graham M B, Kelkar S, DenBesten K and Quinn J P 2001 Lancet 357 1197

    Article  Google Scholar 

  5. Tsiodras S, Golod H S, Sakoulas G, Eliopoulos G M, Wennersten C, Venkataraman L, Moellering R C and Ferraro M J 2001 Lancet 358 207

    Article  CAS  Google Scholar 

  6. Xiong L, Kloss P, Douthwaite S, Anderson N M, Swaney S, Shinabarge D C and Mankin A S 2000 J. Bacteriol. 182 5325

    Article  CAS  Google Scholar 

  7. Mutnick A H, Enne V and Jones R N 2003 Ann. Phermacother. 37 769

    Article  CAS  Google Scholar 

  8. Brunton L, Lazo J S and Parker K L 2006 In The Pharmacological Basis of Therapeutics 11th edn. (New York: Goodman & Gilman’s)

  9. Scozzafava A, Owa T, Mastrolorenzo A and Supuran C T 2003 Curr. Med. Chem. 10 925

    Article  CAS  Google Scholar 

  10. Supuran C T, Scozzafava A and Casini A 2003 Med. Res. Rev. 23 146

    Article  CAS  Google Scholar 

  11. Casini A, Scozzafava A, Mastrolorenzo A and Supuran C T 2002 Curr. Cancer. Drug. Targets 2 55

    Article  CAS  Google Scholar 

  12. Owa T and Nagasu T 2000 Exp. Opin. Ther. Pat. 10 1725

    Article  CAS  Google Scholar 

  13. Supuran C T and Scozzafava A 2002 Exp. Opin. Ther. Pat. 12 217

    Article  CAS  Google Scholar 

  14. Supuran C T and Scozzafava A 2001 Curr. Med. Chem. Imm. Endoc. Metab. Agents 1 61

    Article  CAS  Google Scholar 

  15. Supuran C T and Scozzafava A 2000 Exp. Opin. Ther. Pat. 10 575

    Article  CAS  Google Scholar 

  16. Owa T, Yoshino H, Okauchi T, Yoshimatsu K, Ozawa Y, Sugi N H, Nagasu T, Koyanagi N and Kitoh K 1999 J. Med. Chem. 42 3789

    Article  CAS  Google Scholar 

  17. Funahashi Y, Sugi N H, Semba T, Yamamoto Y, Hamaoka S, Tsukahara-Tamai N, Ozawa Y, Tsuruoka A, Nara K, Takahashi K, Okabe T, Kamata J, Owa T, Ueda N, Haneda T, Yonaga M, Yoshimatsu K and Wakabayashi T 2002 Cancer Res. 62 6116

    CAS  Google Scholar 

  18. Abbate F, Casini A, Owa T, Scozzafava A and Supuran C T 2004 Bioorg. Med. Chem. Lett. 14 217

    Article  CAS  Google Scholar 

  19. Brown G M 1971 Adv. Enzymol. Relat. Areas Mol. Biol. 35 35

    CAS  Google Scholar 

  20. Ford C W, Zurenko G E and Barbachyn M R 2001 Curr. Drug Targ.-Infect. Dis. 1 181

    Article  CAS  Google Scholar 

  21. Wayne P A 1997 National Committee for Clinical Laboratory Standards Approved Standard. M7-A4 M27

  22. (a) Jorgensen J H, Turnidge J D, Washington J A 1999 In Manual of Clinical Microbiology 7th ed. Murray P R, Pfaller M A, Tenover F C, Baron E J and Yolken R H (eds.) (Washington, DC: ASM Press) pp. 1526-1543; (b) National committee for Clinical Laboratory Standards. Performance Standards for antimicrobial susceptibility testing; ninth informational supplement. 1999 M100-S9 Vol 19 No. 1 (Wayne, Pennsylvania: NCCLS) Table 21

  23. Kartal M, Yýldýz S, Kaya S, Kurucu S and Topc U G 2003 J. Ethnopharmacol. 86 69

    Article  CAS  Google Scholar 

  24. Berredjem M, Bouchareb F, Ait Kaki S, Dekhil M and Aouf N E 2013 Arab. J. Chem. doi: 10.1016/j.arabjc.2013.01.016

  25. Bouchareb F, Boufas W, Cheloufi H, Berredjem M and Aouf N E 2014 Phosphorus Sulfur Silicon Relat. Elem. 189 587

    Article  CAS  Google Scholar 

  26. (a) Barbey C, Bouasla R, Berredjem M, Dupont N, Retailleau P, Aouf N E and Lecouvey M 2012 Tetrahedron 68 9125; (b) Berredjem M, Bouasla R, Aouf N and Barbey C 2010 X-ray Structure Analysis on Line 26 13

  27. Berredjem M, Regainia Z, Dewynter G, Montero J L and Aouf N E 2006 Heteroat. Chem. 17 1

    Article  Google Scholar 

  28. Bouasla R, Berredjem H, Berredjem M, Ibrahim-Oualid M, Allaoui A, Lecouvey M and Aouf N E 2013 J. Het. Chem. 50 1328

    Article  CAS  Google Scholar 

  29. Cheloufi H, Berredjem M, Boufas W, Bouchareb F, Djahoudi A and Aouf N E 2014 Phosphorus, Sulfur Silicon Relat. Elem. 189 1396

    Article  Google Scholar 

  30. (a) Bouchouk D, Colacino E, Toupet L, Aouf N E, Martinez J and Dewynter G 2009 Tetrahedron Lett. 50 1100; (b) Berredjem M, Djebbar H, Regaïnia Z, Aouf N E, Dewynter G, Winum J Y and Montero J L 2003 Phosphorus, Sulfur Silicon Relat. Elem. 178 693

Download references

Acknowledgments

This work was generously supported by the Direction Générale de la Recherche Scientifique et du Développement Technologique, DGRS-DT, Algerian Ministry of Scientific Research (FNR 2000).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to MALIKA BERREDJEM.

Additional information

Supplementary Information

All additional information pertaining to characterization of the N-sulfamoyloxazolidin-2-ones using ESI-MS technique (figures S14, S15), 1H NMR spectrum (figures S8, S10, S12, S13), 13C NMR spectrum (figures S9, S11), are given in the supporting information which available at www.ias.ac.in/chemsci.

Electronic supplementary material

Below is the link to the electronic supplementary material.

(DOC 5.25 MB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

BOUCHAREB, F., BERREDJEM, M., KAKI, S.A. et al. Synthesis and antibacterial activity of new chiral N-sulfamoyloxazolidin-2-ones. J Chem Sci 128, 85–91 (2016). https://doi.org/10.1007/s12039-015-1004-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12039-015-1004-x

Keywords

Navigation